These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12882711)
1. [The combination of octreotide to rofecoxib enhanced the inhibitory effect on growth of human hepatocellular carcinoma]. Liu CL; Tang CW; Zhou XC Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):313-5. PubMed ID: 12882711 [TBL] [Abstract][Full Text] [Related]
2. [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma]. Tang CW; Tang LP; Wang CH Ai Zheng; 2002 Apr; 21(4):383-7. PubMed ID: 12452016 [TBL] [Abstract][Full Text] [Related]
3. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo]. Wang C; Tang C; Tang L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709 [TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer. Tang C; Liu C; Zhou X; Wang C Int J Cancer; 2004 Nov; 112(3):470-4. PubMed ID: 15382074 [TBL] [Abstract][Full Text] [Related]
5. [The effects of selective cyclooxygenase-2 inhibitors on the growth of gastric adenocarcinoma]. Liu C; Tang C; Wan X; Wang C; Zhou X Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):480-3. PubMed ID: 12910695 [TBL] [Abstract][Full Text] [Related]
6. Effect of octreotide on angiogenesis induced by hepatocellular carcinoma in vivo. Jia WD; Xu GL; Sun HC; Wang L; Xu RN; Xue Q Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):404-9. PubMed ID: 14599948 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide]. Wang CH; Tang CW Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study. Ghous Z; Akhter J; Pourgholami MH; Morris DL Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the inhibitory effect of tripeptide tyroservatide on growth of human hepatocellular carcinoma using a hollow fiber assay]. Shi LX; Lu R; Wang L; Zhou CL; Xu Q; Zhu ZF; Ma R; Zhang HL; Jia J; Fu Z; Yao Z Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):725-8. PubMed ID: 19173797 [TBL] [Abstract][Full Text] [Related]
10. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells. Liu HL; Huo L; Wang L Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line. Gong ZB; Liu JM; Li YM Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531 [TBL] [Abstract][Full Text] [Related]
12. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis. Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043 [TBL] [Abstract][Full Text] [Related]
13. [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2]. Xie Y; Tang CW; Wang CH Ai Zheng; 2005 Aug; 24(8):965-9. PubMed ID: 16086874 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model. Lin RX; Tuo CW; Lü QJ; Zhang W; Wang SQ Acta Pharmacol Sin; 2005 Jun; 26(6):762-8. PubMed ID: 15916744 [TBL] [Abstract][Full Text] [Related]
15. [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice]. Chen S; Xie Y; Wang CH; Tang CW Ai Zheng; 2009 Jul; 28(7):673-8. PubMed ID: 19624890 [TBL] [Abstract][Full Text] [Related]
16. Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer. Treiber G; Röcken C; Wex T; Malfertheiner P Z Gastroenterol; 2007 May; 45(5):369-77. PubMed ID: 17503315 [TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166 [TBL] [Abstract][Full Text] [Related]
18. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy]. Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo. Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]